XML 38 R27.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following is a summary of our segment and consolidated net loss, including significant segment expenses:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(in thousands)
Collaboration revenue
$— $— $— $1,885 
Less:
Clinical development5,802 4,162 15,841 12,574 
General and administrative support3,350 3,437 10,659 10,797 
Research and discovery3,692 4,125 10,548 11,670 
Manufacturing1,247 2,935 7,945 11,800 
Other segment expenses(a)
1,635 2,465 6,266 8,290 
Interest income697 1,598 2,544 5,364 
Interest expense(1,341)(1,244)(3,905)(3,389)
Loss on extinguishment of debt— — — (553)
Other income, net— 97 179 1,709 
Segment and consolidated net loss$(16,370)$(16,673)$(52,441)$(50,115)
(a) Other segment expenses includes non-cash expenses for stock-based compensation and depreciation expenses.